Kairos Pharma KAPA
NYSE KAPA
$0.60 +0.02 (+2.71%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Shares Outstanding (Entity) (2023 - 2025)

Updated

Kairos Pharma (KAPA) reported Shares Outstanding (Entity) of 20.82 million for Q4 2025, up 83.3% from 11.36 million a year earlier.

Analysis

Kairos Pharma (KAPA) Shares Outstanding (Entity) (2023 - 2025) Analysis & Trends

Dating back to Q3 2023, Kairos Pharma's Shares Outstanding (Entity) record includes 9 quarters.

  • By year, Shares Outstanding (Entity) came in at 11.36 million in FY2024 (+7.5%) and 10.56 million in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 941.36 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.41 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.77 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 540.60 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 1.24 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 5.70 Bn
10 Kairos Pharma 10.86 Mn -1.55 Mn - 20.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.82 Mn
Jun 30, 2025 17.74 Mn
Mar 31, 2025 15.83 Mn
Dec 31, 2024 11.36 Mn
Sep 30, 2024 12.85 Mn
Jun 30, 2024 10.56 Mn
Mar 31, 2024 10.56 Mn
Dec 31, 2023 10.56 Mn
Sep 30, 2023 10.33 Mn
API Access

Kairos Pharma Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=KAPA&period=max&api_key=YOUR_API_KEY